KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $23.2 million.

  • Fulgent Genetics' Other Non-Current Assets fell 4050.29% to $23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year decrease of 4050.29%. This contributed to the annual value of $33.5 million for FY2024, which is 413.16% down from last year.
  • Fulgent Genetics' Other Non-Current Assets amounted to $23.2 million in Q3 2025, which was down 4050.29% from $23.3 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Other Non-Current Assets peaked at $61.8 million during Q2 2022, and registered a low of $5.3 million during Q1 2021.
  • Over the past 5 years, Fulgent Genetics' median Other Non-Current Assets value was $33.5 million (recorded in 2024), while the average stood at $32.6 million.
  • In the last 5 years, Fulgent Genetics' Other Non-Current Assets surged by 1102125.0% in 2021 and then plummeted by 4050.29% in 2025.
  • Fulgent Genetics' Other Non-Current Assets (Quarter) stood at $10.6 million in 2021, then surged by 314.31% to $44.1 million in 2022, then dropped by 20.9% to $34.9 million in 2023, then decreased by 4.13% to $33.5 million in 2024, then crashed by 30.63% to $23.2 million in 2025.
  • Its last three reported values are $23.2 million in Q3 2025, $23.3 million for Q2 2025, and $32.7 million during Q1 2025.